Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

Externalized nurse-led model for hepatitis C virus microelimination and impact of drug use profile Anna Miralpeix; Paula Ibáñez; Víctor Navarro; Patricia Colomera; Montserrat Gálvez; Zoe Mariño; Xavier Major; Joan Colom; Xavier Forns; Sabela Lens;

Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C Georgios Neokosmidis; Adonis A. Protopapas; Dimitrios Stogiannou; Athanasios Filippidis; Konstantinos Tziomalos;